3 Reasons to Avoid CBRE and 1 Stock to Buy Instead CBRE currently trades at $118.95 per share and has shown little upside over the past six months, posting a small loss of 4.4%. Is there a buying opportunity in CBRE, or does it present a risk to your portfolio? Get the full breakdown from our expert analysts, it’s free. We're sitting this one out for now. Here are three reasons why you should be careful with CBRE and a stock we'd rather own. Why Do We Think CBRE Will Underperform? Established in 1906, CBRE (NYSE:CBRE) is one of the largest commercial real estate services firms in the world. 1. Long-Term Revenue Growth Disappoints Examining a company’s long-term performance can provide clues about its quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Unfortunately, CBRE’s 8.4% annualized revenue growth over the last five years was sluggish. This was below our standard for the consumer discretionary sector.CBRE Quarterly Revenue 2. Weak Operating Margin Could Cause Trouble Operating margin is a key measure of profitability. Think of it as net income - the bottom line - excluding the impact of taxes and interest on debt, which are less connected to business fundamentals. CBRE’s operating margin might fluctuated slightly over the last 12 months but has generally stayed the same, averaging 3.7% over the last two years. This profitability was lousy for a consumer discretionary business and caused by its suboptimal cost structure.CBRE Trailing 12-Month Operating Margin (GAAP) 3. Mediocre Free Cash Flow Margin Limits Reinvestment Potential Free cash flow isn't a prominently featured metric in company financials and earnings releases, but we think it's telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king. CBRE has shown poor cash profitability over the last two years, giving the company limited opportunities to return capital to shareholders. Its free cash flow margin averaged 2.3%, lousy for a consumer discretionary business.CBRE Trailing 12-Month Free Cash Flow Margin Final Judgment We see the value of companies helping consumers, but in the case of CBRE, we’re out. That said, the stock currently trades at 19.8× forward price-to-earnings (or $118.95 per share). This valuation tells us a lot of optimism is priced in - we think there are better stocks to buy right now. We’d suggest looking at a top digital advertising platform riding the creator economy. Stocks We Would Buy Instead of CBRE Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. Story Continues While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years. Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like Sterling Infrastructure (+1,096% five-year return). Find your next big winner with StockStory today for free. View Comments
3 Reasons to Avoid CBRE and 1 Stock to Buy Instead
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...